Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Abcam, Shuwen Biotech link up for CDx kits
July 2018
SHARING OPTIONS:

CAMBRIDGE, U.K. & DEQING, China—Abcam and Shuwen Biotech have signed a memorandum of understanding under which they will jointly apply their expertise in the production of high-quality antibodies and the development and commercialization of companion diagnostic kits.
 
“Shuwen has a long-standing reputation amongst pharmaceutical companies for companion diagnostic kit development and central lab testing, and Abcam is a recognized leader in quality antibody development. This alliance will undoubtedly further strengthen Shuwen’s capabilities in developing quality companion diagnostic kits especially immunoassay kits,” said Jay Z. Zhang, Shuwen’s chairman and CEO. “We have seen continuous advances at all levels in personalized medicine over the past few years and these can only continue through innovative technologies like those that will be born out of joint efforts between Shuwen and Abcam.”

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2018 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.